An Open Label, Randomized, Single Dose and Multiple Dose Trial to Assess the Pharmacokinetics of Obeticholic Acid (OCA)

Trial Profile

An Open Label, Randomized, Single Dose and Multiple Dose Trial to Assess the Pharmacokinetics of Obeticholic Acid (OCA)

Completed
Phase of Trial: Phase I

Latest Information Update: 04 Dec 2013

At a glance

  • Drugs Obeticholic acid (Primary)
  • Indications Crohn's disease; Non-alcoholic steatohepatitis; Portal hypertension; Primary bile acid malabsorption; Primary biliary cirrhosis
  • Focus Pharmacokinetics
  • Most Recent Events

    • 01 Nov 2013 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
    • 06 Sep 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top